Search by Drug Name or NDC
NDC 61703-0342-50 Paclitaxel 6 mg/mL Details
Paclitaxel 6 mg/mL
Paclitaxel is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is PACLITAXEL.
MedlinePlus Drug Summary
Paclitaxel (with polyoxyethylated castor oil) is used along or along with other chemotherapy medications to treat breast cancer, ovarian cancer (cancer that begins in the female reproductive organs where eggs are formed), and non-small cell lung cancer (NSCLC). Paclitaxel (with polyoxyethylated castor oil) injection is also used to treat Kaposi's sarcoma (a type of cancer that causes patches of abnormal tissue to grow under the skin) in people who have acquired immunodeficiency syndrome (AIDS). Paclitaxel is in a class of medications called antimicrotubule agents. It works by stopping the growth and spread of cancer cells.
Related Packages: 61703-0342-50Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Paclitaxel (with polyoxyethylated castor oil) Injection
Product Information
| NDC | 61703-0342 |
|---|---|
| Product ID | 61703-342_fe666b6c-20ba-4861-87b4-d8e45cfddb36 |
| Associated GPIs | 21500012001325 21500012001335 21500012001350 |
| GCN Sequence Number | 046997 |
| GCN Sequence Number Description | paclitaxel VIAL 6 MG/ML INTRAVEN |
| HIC3 | V1F |
| HIC3 Description | ANTINEOPLASTICS,MISCELLANEOUS |
| GCN | 85602 |
| HICL Sequence Number | 007625 |
| HICL Sequence Number Description | PACLITAXEL |
| Brand/Generic | Generic |
| Proprietary Name | Paclitaxel |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | PACLITAXEL |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 6 |
| Active Ingredient Units | mg/mL |
| Substance Name | PACLITAXEL |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Microtubule Inhibition [PE], Microtubule Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076131 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61703-0342-50 (61703034250)
| NDC Package Code | 61703-342-50 |
|---|---|
| Billing NDC | 61703034250 |
| Package | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-342-50) / 50 mL in 1 VIAL, MULTI-DOSE |
| Marketing Start Date | 2004-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |